These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 8463111

  • 1. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
    Oddone EZ, Cowper PA, Hamilton JD, Feussner JR.
    Health Serv Res; 1993 Apr; 28(1):97-121. PubMed ID: 8463111
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L, Thornton L, O'Flanagan D, Johnson H, Barry M.
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [Abstract] [Full Text] [Related]

  • 3. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF, Chen TH.
    Vaccine; 2009 Nov 12; 27(48):6770-6. PubMed ID: 19735755
    [Abstract] [Full Text] [Related]

  • 4. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK, Hutton G, Das Dores Pascoal E.
    Health Policy Plan; 2005 Jan 12; 20(1):50-9. PubMed ID: 15689430
    [Abstract] [Full Text] [Related]

  • 5. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY, Billah K, Lieu TA, Weinstein MC.
    Am J Prev Med; 2006 Jun 12; 30(6):498-506. PubMed ID: 16704944
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX, Dang RB, Zhang WD, Liang XF, Cui FQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct 12; 29(10):1003-8. PubMed ID: 19173882
    [Abstract] [Full Text] [Related]

  • 9. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
    Alavian SM, Tabatabaei SV.
    Clin Ther; 2010 Jan 12; 32(1):1-10. PubMed ID: 20171406
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.
    Pediatrics; 2005 Jun 12; 115(6):1675-84. PubMed ID: 15930232
    [Abstract] [Full Text] [Related]

  • 13. [Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
    Fernández Barboza R, Rivero D, Echeverría B, Machado IV.
    Bol Oficina Sanit Panam; 1991 Jul 12; 111(1):16-23. PubMed ID: 1834080
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team.
    Pediatrics; 2005 May 12; 115(5):1220-32. PubMed ID: 15867028
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults.
    O'Connor JB, Imperiale TF, Singer ME.
    Hepatology; 1999 Oct 12; 30(4):1077-81. PubMed ID: 10498662
    [Abstract] [Full Text] [Related]

  • 16. [Cost-benefit analysis of vaccinal prevention of hepatitis B policy].
    Kerleau M, Flori YA, Nalpas B, Lanoé JL, Berthelot P, Fardeau-Gautier M.
    Rev Epidemiol Sante Publique; 1995 Oct 12; 43(1):48-60. PubMed ID: 7892516
    [Abstract] [Full Text] [Related]

  • 17. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
    Mulley AG, Silverstein MD, Dienstag JL.
    N Engl J Med; 1982 Sep 09; 307(11):644-52. PubMed ID: 6810170
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [A cost-effectiveness analysis of vaccination against the hepatitis B virus].
    Antoñanzas F, Forcén T, Garuz R.
    Med Clin (Barc); 1992 Jun 06; 99(2):41-6. PubMed ID: 1630178
    [Abstract] [Full Text] [Related]

  • 20. [Cost-effectiveness analysis of different alternatives of universal vaccination against hepatitis B in the region of Murcia].
    Guillén Grima F, Espín Ríos MI.
    Med Clin (Barc); 1995 Feb 04; 104(4):130-6. PubMed ID: 7898156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.